Table 3.
Predicted pharmacokinetics properties for druglikeliness of top ranked ligands.
| Compound Name | Aqueous Solubility | Solubility class | BBB permeant | CYP2D6 inhibitor | P Glycoprotein substrate | GI absorption |
|---|---|---|---|---|---|---|
| Andrographolide | −3.18 | Soluble | No | No | Yes | High |
| Hydro andrographolide | −3 | Soluble | No | No | Yes | High |
| Iso andrographolide | −3.35 | Soluble | No | Yes | Yes | High |
| Neo andrographolide | −4.01 | Moderately soluble | No | No | Yes | High |
| Oxo andrographolide | −2.79 | Soluble | No | No | Yes | High |
| Mulberroside A | −2.53 | Soluble | No | No | No | High |
| Mulberroside C | −3.79 | Soluble | No | No | No | Low |
| Mulberroside E | −2.66 | Soluble | No | No | No | Low |
| Mulberroside F | −2.73 | Soluble | No | No | Yes | Low |
| Mimusopic acid | −5.91 | Moderately soluble | No | No | No | High |
| Nimbolide | −3.94 | Soluble | No | No | Yes | High |
| Emblicanin A | −5.63 | Moderately soluble | No | No | Yes | Low |
| Punigluconin | −5.17 | Moderately soluble | No | No | Yes | Low |
| Chebulic acid | −1.39 | Soluble | No | No | No | Low |
| Anolignan A | −5.17 | Moderately soluble | Yes | Yes | No | High |
| Anolignan B | −5.07 | Moderately soluble | Yes | Yes | No | High |
| Anolignan C | −4.28 | Moderately soluble | Yes | Yes | Yes | High |